Hepatobiliary Surgery — MCQs

A 40-year-old obese woman presents with a long history of vague upper abdominal pain and frequent indigestion. She has jaundice and abdominal tenderness. Her serum bilirubin is elevated at 4.2 mg/dL. There is a mild increase in serum AST and ALT (62 and 57 U/L, respectively) and a moderate increase in alkaline phosphatase (325 U/L). Markers for viral hepatitis are negative. Abdominal ultrasound shows echogenic stone-like material within the gallbladder and thickening of the gallbladder wall, with an intrahepatic mass visualized adjacent to the gallbladder. Following a cholecystectomy, histologic examination of the gallbladder wall reveals dense fibrosis and glandular structures. What is the most likely diagnosis?

Q99Easy

Which of the following is NOT included in the criteria for assessing a child's condition?

Q100Easy

What is the treatment for polycystic liver disease?

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 91: Bile duct strictures are seen in all except?

A. CBD stone
B. Cholangiocarcinoma
C. Trauma
D. Acute pancreatitis (Correct Answer)

Explanation: **Explanation:** Bile duct strictures are narrowing of the biliary tree caused by inflammatory, neoplastic, or traumatic processes. **Why Acute Pancreatitis is the Correct Answer:** In **Acute Pancreatitis**, the primary pathology is acute inflammation and edema of the pancreatic parenchyma. While it can cause transient compression of the intrapancreatic portion of the Common Bile Duct (CBD) due to edema, it does **not** typically result in a permanent fibrotic stricture. In contrast, **Chronic Pancreatitis** is a well-known cause of biliary strictures due to recurrent inflammation leading to periductal fibrosis. **Analysis of Other Options:** * **CBD Stone:** Long-standing or impacted gallstones cause mechanical irritation and pressure necrosis of the ductal wall. This leads to inflammation and subsequent healing by fibrosis, resulting in an inflammatory stricture. * **Cholangiocarcinoma:** This is a primary malignancy of the bile duct epithelium. It typically presents as a "shoulder-effect" or "apple-core" malignant stricture due to infiltrative growth. * **Trauma:** Iatrogenic trauma (most commonly during laparoscopic cholecystectomy) is the leading cause of benign biliary strictures. Ischemic injury or direct ductal damage leads to scarring and narrowing. **Clinical Pearls for NEET-PG:** * **Most common cause of benign stricture:** Iatrogenic injury (Post-cholecystectomy). * **Most common cause of malignant stricture:** Cholangiocarcinoma. * **Primary Sclerosing Cholangitis (PSC):** Characterized by multiple "beaded" strictures on ERCP/MRCP. * **Mirizzi Syndrome:** An extrinsic compression of the hepatic duct by a stone impacted in the cystic duct, which can lead to a stricture.

Question 92: Rigler's triad consists of all except?

A. Intestinal obstruction
B. Gas in bile duct
C. Cholangitis (Correct Answer)
D. Ectopic gallstone

Explanation: **Explanation:** **Rigler’s Triad** is the classic radiological finding associated with **Gallstone Ileus**, a rare complication of chronic cholecystitis where a large gallstone erodes through the gallbladder wall into the duodenum (forming a cholecystoenteric fistula). **Why Cholangitis is the correct answer:** Cholangitis refers to the inflammation/infection of the bile duct system. While patients with gallstone ileus have a history of gallbladder disease, **Cholangitis is NOT a component of Rigler’s Triad.** The triad focuses on the mechanical consequences of the stone's migration and the resulting bowel obstruction. **Analysis of Incorrect Options (Components of the Triad):** * **A. Intestinal Obstruction:** The ectopic stone typically impacts at the narrowest part of the small bowel, the **ileocecal valve**, leading to mechanical small bowel obstruction (dilated loops with air-fluid levels). * **B. Gas in bile duct (Pneumobilia):** Because of the fistula between the gallbladder and the bowel, air from the gut travels retrograde into the biliary tree. * **D. Ectopic gallstone:** A radiopaque gallstone is visualized in an abnormal location, usually the right iliac fossa. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of impaction:** Terminal Ileum (Ileocecal valve). * **Most common site of fistula:** Cholecystoduodenal fistula. * **Rigler’s Sign vs. Triad:** Do not confuse *Rigler’s Triad* (Gallstone ileus) with *Rigler’s Sign* (double wall sign seen in pneumoperitoneum). * **Treatment:** The priority is a laparotomy with **enterolithotomy** (removal of the stone). The fistula is usually addressed in a second stage.

Question 93: Which of the following is NOT true about Hepatocellular Carcinoma (HCC)?

A. It has a high incidence in East Africa and South East Asia.
B. Its worldwide incidence parallels the prevalence of Hepatitis B.
C. Over 80% of tumors are surgically resectable. (Correct Answer)
D. Liver transplantation offers the only chance of cure in those with unresectable disease.

Explanation: **Explanation:** **1. Why Option C is the correct answer (The False Statement):** In clinical practice, **less than 20% of Hepatocellular Carcinoma (HCC) cases are surgically resectable** at the time of diagnosis. Resectability is limited by two main factors: the extent of the tumor (often multifocal or involving major vessels) and the underlying liver function. Since most HCCs arise in the setting of cirrhosis, the "future liver remnant" is often insufficient to support life, making aggressive resection impossible for the majority of patients. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** HCC shows significant geographical variation. It is highly endemic in **East Africa and South East Asia** due to the high prevalence of chronic Hepatitis B and exposure to Aflatoxin B1. * **Option B:** Globally, **Hepatitis B Virus (HBV)** is the most common risk factor for HCC. The incidence maps of HCC closely mirror the prevalence maps of chronic HBV carriers. * **Option C:** For patients with unresectable disease but localized tumors (meeting **Milan Criteria**), **Liver Transplantation** is the gold standard. It is curative because it treats both the tumor and the underlying precancerous cirrhotic liver. **High-Yield Clinical Pearls for NEET-PG:** * **Tumor Marker:** Alpha-fetoprotein (AFP) is the most common marker (levels >400 ng/mL are highly suggestive). * **Screening:** USG + AFP every 6 months for high-risk (cirrhotic) patients. * **Radiology:** HCC shows **"Arterial Enhancement"** and **"Venous Washout"** on triphasic CT/MRI. * **Milan Criteria for Transplant:** Single lesion ≤5 cm OR up to 3 lesions each ≤3 cm, with no vascular invasion/extrahepatic spread.

Question 94: What is the most common cause of pancreatitis?

A. Idiopathic
B. Iatrogenic
C. Gallstones (Correct Answer)
D. Alcohol

Explanation: **Explanation:** Acute pancreatitis is a common surgical emergency characterized by inflammation of the pancreas. Globally, and specifically in the context of NEET-PG, **Gallstones (Option C)** are recognized as the **most common cause** of acute pancreatitis, accounting for approximately 40–50% of cases. The mechanism involves the migration of a gallstone into the common bile duct, leading to transient or persistent obstruction of the Ampulla of Vater. This causes reflux of bile into the pancreatic duct or increased intraductal pressure, triggering premature activation of pancreatic enzymes (trypsinogen to trypsin) and subsequent autodigestion of the gland. **Analysis of Incorrect Options:** * **Alcohol (Option D):** This is the **second most common cause** overall (approx. 30%) and the most common cause of *chronic* pancreatitis. In certain demographics (e.g., males in specific regions), it may rival gallstones, but statistically, gallstones remain the leading cause. * **Idiopathic (Option A):** About 10–20% of cases have no identifiable cause after routine workup. However, many "idiopathic" cases are later found to be due to biliary sludge or microlithiasis. * **Iatrogenic (Option B):** Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) is a well-known iatrogenic cause, but it accounts for a very small percentage of total cases. **Clinical Pearls for NEET-PG:** * **Mnemonic (GET SMASHED):** **G**allstones, **E**thanol, **T**rauma, **S**teroids, **M**umps, **A**utoimmune, **S**corpion sting, **H**ypertriglyceridemia/Hypercalcemia, **E**RCP, **D**rugs (e.g., Azathioprine, Thiazides). * **Diagnosis:** Requires 2 out of 3: (1) Acute epigastric pain radiating to the back, (2) Serum Amylase/Lipase >3x normal, (3) Characteristic findings on CECT. * **Lipase** is more specific and remains elevated longer than Amylase.

Question 95: Which of the following is NOT used to describe the oncological outcome in Hepatocellular Carcinoma (HCC)?

A. MELD score (Correct Answer)
B. BCLC staging system
C. CLIP score
D. Okuda score

Explanation: **Explanation:** The **MELD (Model for End-Stage Liver Disease) score** is the correct answer because it is a measure of **liver dysfunction and mortality risk**, not an oncological staging system. It is calculated using Bilirubin, Creatinine, and INR. While it is used to prioritize patients for liver transplantation (including those with HCC), it does not account for tumor characteristics like size, number, or vascular invasion. **Analysis of other options:** * **BCLC (Barcelona Clinic Liver Cancer) Staging:** This is the "Gold Standard" for HCC. It is unique because it combines tumor stage, liver function (Child-Pugh), and patient performance status to provide both prognosis and treatment algorithms. * **CLIP (Cancer of the Liver Italian Program) Score:** This is an oncological score that incorporates the Child-Pugh stage, tumor morphology (unifocal vs. massive), Alpha-fetoprotein (AFP) levels, and the presence of portal vein thrombosis. * **Okuda Score:** An older staging system that was the first to combine tumor size (more or less than 50% of the liver) with markers of liver failure (ascites, albumin, bilirubin). **Clinical Pearls for NEET-PG:** * **MELD Score Formula:** $3.78 \times \ln[\text{bilirubin (mg/dL)}] + 11.2 \times \ln[\text{INR}] + 9.57 \times \ln[\text{creatinine (mg/dL)}] + 6.43$. * **Milan Criteria:** Used to determine eligibility for transplant in HCC (Single nodule $\leq 5$ cm or up to 3 nodules each $\leq 3$ cm). * **AFP:** The most common tumor marker for HCC; levels $>400$ ng/mL are highly suggestive in the presence of a liver mass.

Question 96: All of the following are indications for PAIR treatment in hydatid cysts, EXCEPT?

A. Size > 5cm
B. Multiloculated
C. Cyst in lung
D. Recurrence after surgery (Correct Answer)

Explanation: **Explanation:** **PAIR (Puncture, Aspiration, Injection, Re-aspiration)** is a minimally invasive percutaneous treatment for Hydatid cysts (caused by *Echinococcus granulosus*). The correct answer is **Option D (Recurrence after surgery)** because recurrence is actually a **primary indication** for PAIR, not a contraindication. When a cyst recurs post-surgery, PAIR is often preferred over a second high-risk surgery. **Why the other options are incorrect (Contraindications for PAIR):** * **Option B (Multiloculated):** This is a relative/absolute contraindication. PAIR is most effective for unilocular cysts (WHO Type CE1 and CE3a). Multiloculated cysts (Type CE2) have multiple internal septa, making it impossible to aspirate all compartments effectively with a single needle. * **Option C (Cyst in lung):** PAIR is **strictly contraindicated** for pulmonary hydatid cysts. The negative intrathoracic pressure and the risk of cyst rupture into the bronchial tree can lead to life-threatening anaphylaxis or tension pneumothorax. * **Option A (Size > 5cm):** While PAIR can be done for various sizes, cysts **< 5cm** are often managed with medical therapy alone (Albendazole). PAIR is typically indicated for cysts **> 5cm** that are symptomatic or at risk of rupture. **High-Yield NEET-PG Pearls:** * **WHO Classification:** PAIR is best for **CE1** (unilocular) and **CE3a** (detached membranes). * **Absolute Contraindications:** Lung/Brain cysts, superficially located cysts (risk of rupture), and cysts communicating with the biliary tree. * **Drug Cover:** Always start **Albendazole** 1 week before and continue for 4 weeks after PAIR to prevent secondary hydatidosis from spillage. * **Scolicidal Agents:** 20% Hypertonic saline or 95% Ethanol are commonly used.

Question 97: The gallbladder of a 51-year-old female patient is characterized by the presence of multiple gallstones, consistent with the diagnosis of cholecystitis. Which of the following tests would be anticipated to be positive in this patient?

A. Rebound tenderness
B. Iliopsoas test
C. Obturator sign
D. Murphy's sign (Correct Answer)

Explanation: **Explanation:** The clinical presentation of a 51-year-old female with gallstones and cholecystitis points directly toward **Murphy’s sign** as the most likely positive physical finding. **1. Why Murphy’s Sign is Correct:** Murphy’s sign is the classic physical exam finding for **acute cholecystitis**. It is elicited by asking the patient to take a deep breath while the examiner applies steady pressure under the right costal margin (at the gallbladder point). As the diaphragm descends, the inflamed gallbladder hits the examiner’s fingers, causing a sudden cessation of inspiration due to sharp pain. This "inspiratory arrest" is highly specific for gallbladder inflammation. **2. Why Other Options are Incorrect:** * **Rebound Tenderness (Blumberg Sign):** While it can occur in late-stage cholecystitis if perforation or localized peritonitis develops, it is a non-specific sign of peritoneal irritation and is more classically associated with generalized peritonitis or acute appendicitis. * **Iliopsoas Test:** This is performed by extending the right hip or having the patient flex the hip against resistance. It indicates irritation of the psoas muscle, typically seen in **retrocecal appendicitis**. * **Obturator Sign:** This involves internal rotation of the flexed right hip. It indicates irritation of the obturator internus muscle, typically seen in **pelvic appendicitis**. **Clinical Pearls for NEET-PG:** * **Boas’ Sign:** Hyperesthesia (increased sensitivity) between the 9th and 11th ribs posteriorly on the right side; another high-yield sign for acute cholecystitis. * **Saint’s Triad:** Cholelithiasis, Hiatus hernia, and Diverticulosis. * **Charcot’s Triad:** Fever, Jaundice, and RUQ pain (indicates **Ascending Cholangitis**, not just cholecystitis). * **Investigation of Choice:** Ultrasonography (USG) is the initial investigation of choice; HIDA scan is the most sensitive/gold standard for diagnosis.

Question 98: A 40-year-old obese woman presents with a long history of vague upper abdominal pain and frequent indigestion. She has jaundice and abdominal tenderness. Her serum bilirubin is elevated at 4.2 mg/dL. There is a mild increase in serum AST and ALT (62 and 57 U/L, respectively) and a moderate increase in alkaline phosphatase (325 U/L). Markers for viral hepatitis are negative. Abdominal ultrasound shows echogenic stone-like material within the gallbladder and thickening of the gallbladder wall, with an intrahepatic mass visualized adjacent to the gallbladder. Following a cholecystectomy, histologic examination of the gallbladder wall reveals dense fibrosis and glandular structures. What is the most likely diagnosis?

A. Carcinoma of the gallbladder (Correct Answer)
B. Hemangiosarcoma
C. Hepatic adenoma
D. Hepatocellular carcinoma

Explanation: **Explanation:** The clinical presentation and histopathology point towards **Gallbladder Carcinoma (GBC)**. 1. **Why Option A is correct:** The patient fits the classic demographic for gallbladder disease (40-year-old, obese female). The presence of jaundice and significantly elevated alkaline phosphatase (325 U/L) suggests obstructive jaundice, often seen when GBC invades the biliary tree or the liver bed. Ultrasound findings of an **intrahepatic mass adjacent to the gallbladder** and gallbladder wall thickening are highly suspicious for malignancy. Histologically, the presence of **glandular structures** (adenocarcinoma) and **dense fibrosis** (desmoplastic reaction) confirms the diagnosis. Chronic cholelithiasis (suggested by the "stone-like material") is the most significant risk factor for GBC. 2. **Why other options are incorrect:** * **Hemangiosarcoma:** A rare vascular tumor of the liver associated with exposure to vinyl chloride or arsenic; it would not typically present with glandular structures or a primary gallbladder pathology. * **Hepatic Adenoma:** Usually associated with oral contraceptive use and presents as a well-circumscribed hypervascular mass, not with obstructive jaundice or glandular infiltration of the gallbladder wall. * **Hepatocellular Carcinoma (HCC):** Typically arises in the setting of chronic cirrhosis or viral hepatitis (both absent here). While it can invade the gallbladder, the primary pathology here originates from the gallbladder wall. **NEET-PG High-Yield Pearls:** * **Most common histological type:** Adenocarcinoma (>90%). * **Risk Factors:** Gallstones (especially >3cm), Porcelain gallbladder, Choledochal cysts, and Primary Sclerosing Cholangitis. * **Nevin’s Staging/AJCC Staging:** Crucial for prognosis; Stage T1a (limited to lamina propria) can be treated with simple cholecystectomy, whereas T1b or higher requires **Radical Cholecystectomy** (cholecystectomy + wedge resection of liver bed + lymphadenectomy). * **Courvoisier’s Law:** In the presence of jaundice, a palpable gallbladder is unlikely to be due to stones; it suggests malignancy (though GBC itself can sometimes present with a palpable mass).

Question 99: Which of the following is NOT included in the criteria for assessing a child's condition?

A. Nutritional status
B. Serum bilirubin
C. Serum albumin (Correct Answer)
D. ALT / AST

Explanation: This question refers to the **Kasai’s Criteria** (also known as the Kasai Prognostic Score), which is used to assess the clinical condition and prognosis of infants with **Biliary Atresia** following a Kasai portoenterostomy. ### Explanation of the Correct Answer **C. Serum Albumin:** While albumin is a marker of liver synthetic function, it is **not** a component of the specific criteria used to assess the immediate postoperative condition or prognosis in the Kasai classification. The criteria focus more on active cholestasis and nutritional impact rather than synthetic protein markers. ### Analysis of Incorrect Options * **A. Nutritional Status:** This is a vital component. Poor weight gain and failure to thrive are significant indicators of ongoing malabsorption and liver dysfunction in biliary atresia. * **B. Serum Bilirubin:** This is the most critical biochemical marker. The clearance of jaundice (Bilirubin < 2 mg/dL) post-surgery is the primary predictor of long-term native liver survival. * **D. ALT / AST:** Serum transaminases are included as markers of ongoing hepatocellular injury and inflammatory activity within the liver parenchyma. ### NEET-PG High-Yield Pearls * **Biliary Atresia (BA):** The most common cause of neonatal cholestasis requiring surgery. * **Kasai Portoenterostomy:** Best performed before **60 days of life**. Success rates drop significantly after 90 days. * **Most Common Type:** Type III (involving the entire extrahepatic biliary tree) is the most frequent (90%). * **Triangular Cord Sign:** A high-yield USG finding in BA representing a cone-shaped fibrotic mass at the porta hepatis. * **Gold Standard Diagnosis:** Intraoperative Cholangiogram (IOC). * **Prognosis:** If the Kasai procedure fails, **Liver Transplantation** is the definitive treatment.

Question 100: What is the treatment for polycystic liver disease?

A. Deroofing of the cyst (Correct Answer)
B. Injection of sclerosant
C. Hepatic resection
D. Liver transplantation

Explanation: **Explanation:** Polycystic Liver Disease (PCLD) is an autosomal dominant condition often associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD). The management strategy is primarily determined by the severity of symptoms and the distribution of the cysts. **1. Why "Deroofing of the cyst" is correct:** For patients with symptomatic PCLD who have large, dominant surface cysts, **Laparoscopic Deroofing (Fenestration)** is the treatment of choice. This procedure involves excising the redundant cyst wall and allowing the fluid to drain into the peritoneal cavity, where it is reabsorbed. It provides significant symptomatic relief with lower morbidity compared to major resections. **2. Why other options are incorrect:** * **Injection of sclerosant:** While useful for isolated simple cysts, aspiration and sclerotherapy (using alcohol or minocycline) are generally ineffective in PCLD because the disease involves hundreds of cysts; treating a few does not resolve the mass effect. * **Hepatic resection:** This is reserved for patients with massive hepatomegaly where the cysts are confined to specific segments (usually one lobe), leaving enough healthy parenchyma. It is not the first-line treatment for general PCLD. * **Liver transplantation:** This is the definitive treatment but is strictly reserved for "end-stage" PCLD characterized by severe malnutrition, portal hypertension, or failure of all other surgical interventions. **High-Yield NEET-PG Pearls:** * **Most common extra-renal manifestation of ADPKD:** Polycystic Liver Disease. * **Gigantism of the liver:** PCLD can cause massive hepatomegaly without compromising liver function (LFTs usually remain normal). * **Gigot’s Classification:** Used to stage PCLD based on the number and distribution of cysts to guide surgical planning. * **Medical Management:** Somatostatin analogues (e.g., Octreotide) can be used to reduce cyst volume by inhibiting secretin-induced fluid secretion.

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free